National trends in prescription drug expenditures and projections for 2021
نویسندگان
چکیده
Abstract Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and predict growth in drug spending 2021 the United States, with a focus on nonfederal hospital clinic sectors. Methods Historical were assessed by examining data purchases from manufacturers using IQVIA National Sales Perspectives database. Factors hospitals clinics reviewed—including new approvals, patent expirations, potential policies or legislation. Focused analyses conducted for biosimilars, cancer drugs, generics, coronavirus disease 2019 (COVID-19) pandemic influence, specialty drugs. For hospitals, clinics, overall (all sectors), estimates expenditures based combination quantitative expert opinion. Results In 2020, States grew 4.9% compared 2019, total $535.3 billion. Utilization (a 2.9% increase) drugs 1.8% drove this increase, price changes having minimal 0.3% increase). Adalimumab was top followed apixaban insulin glargine. Drug $35.3 billion 4.6% decrease) $98.4 (an 8.1% respectively. driven products increased utilization, whereas decrease reduced utilization. Several will are expected be approved 2021. Specialty continue drive along evolution COVID-19 pandemic. Conclusion 2021, we expect prescription rise 4% 6%, anticipate increases 7% 9% 3% 5%, respectively, 2020. These national expenditure not representative any particular health system because myriad local actual spending.
منابع مشابه
National trends in prescription drug expenditures and projections for 2016.
PURPOSE Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2016 in nonfederal hospitals, clinics, and overall (all sectors). METHODS Drug expenditure data through calendar year 2015 were obtained from the IMS Health National Sales Perspectives database and analyzed. Other factors that may influence ...
متن کاملNational health expenditures projections through 2030
If current laws and practices continue, health expenditures in the United States will reach $1.7 trillion by the year 2000, an amount equal to 18.1 percent of the Nation's gross domestic product (GDP). By the year 2030, as America's baby boomers enter their seventies and eighties, health spending will top $16 trillion, or 32 percent of GDP. The projections presented here incorporate the assumpt...
متن کاملFactors Contributing to Increases in Prescription Drug Expenditures Borne by National Health Insurance in South Korea
PURPOSE Rapid growth of prescription drug expenditures is a problem in South Korea. The objective of this study was to assess the contributions of four variables (therapeutic choice, drug-mix, original use, and price changes) to increases in drug expenditures paid by the National Health Insurance (NHI) in Korea. MATERIALS AND METHODS A retrospective cohort study was conducted between January ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Health-system Pharmacy
سال: 2021
ISSN: ['1079-2082', '1535-2900']
DOI: https://doi.org/10.1093/ajhp/zxab160